Our findings provide valuable guidance for developing interventions to address suboptimal HPV vaccination in high-risk groups.
No takes yet. Share an insight, caveat, or question.
Bastani et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: